NUVB · Nuvation Bio Inc.
$6.43
+0.17 (+2.72%)
At close · Jul 21
Market Cap
$2.24B
Shares
348.20M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-06 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-30 | 2026-06-24 | |
| 8-K | 2026-05-27 | 2026-05-21 | |
| 8-K | 2026-05-04 | — | |
| 10-Q | 2026-05-04 | 2026-03-31 | |
| DEF 14A | 2026-04-10 | 2026-05-21 | |
| 10-K | 2026-03-02 | 2025-12-31 | |
| 8-K | 2026-03-02 | — | |
| 8-K | 2026-01-12 | 2026-01-11 | |
| 8-K | 2025-11-26 | — | |
| 8-K | 2025-11-17 | — | |
| 10-Q | 2025-11-03 | 2025-09-30 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-11 | — | |
| 8-K | 2025-05-23 | 2025-05-21 | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| DEF 14A | 2025-04-08 | 2025-05-21 | |
| 8-K | 2025-03-25 | 2025-03-21 | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2025-03-06 | — | |
| 8-K | 2025-03-05 | 2025-03-03 | |
| 8-K | 2025-03-04 | 2025-03-03 | |
| 8-K | 2025-02-12 | 2025-02-11 | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-10-07 | — | |
| 8-K | 2024-09-05 | 2024-09-03 | |
| 8-K | 2024-08-05 | — | |
| 10-Q | 2024-08-05 | 2024-06-30 | |
| DEF 14A | 2024-07-30 | 2024-09-03 | |
| 8-K/A | 2024-06-20 | 2024-04-09 | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 8-K | 2024-05-14 | — | |
| 10-K/A | 2024-04-26 | 2023-12-31 | |
| 8-K | 2024-04-10 | 2024-04-09 | |
| 8-K | 2024-03-25 | 2024-03-24 | |
| 10-K | 2024-02-29 | 2023-12-31 | |
| 8-K | 2024-02-29 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-14 | 2023-12-11 | |
| 8-K | 2023-11-27 | — | |
| 8-K | 2023-11-13 | 2023-11-09 | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 10-Q | 2023-08-03 | 2023-06-30 |
Showing 1–50 of 93 filings
Key facts
CIK
1811063
CUSIP
67080N101
13F (30d)
18 filings
18 filers
Visit website
Investor relations